Skip to content
An Initiative of AVAC
Search
Back to Country Data

Country Overview:
Namibia

Global PrEP Tracker
Last Updated: 19 November 2024

Drug Registration Status

Approved
Not
Approved
Under
Review
Data not
available
Gilead's Truvada (TDF/xTC*) Registration
Approved N/A N/A
Generic versions of TDF/xTC* for prevention
Approved N/A N/A
ViiV's Apretude (CAB for PrEP) Registration
Approved 2024 2024
IPM's Dapivirine Vaginal Ring Registration
Approved 2023 2023
Oral F/TAF (Descovy) Registration
Data Not Available
* TDF/xTC refers to tenofovir disoproxil fumarate (TDF) and either emtricitabine (FTC) or lamivudine (3TC)

Research, Demonstration and Implementation

Oral PrEP

2 Completed Projects

Dapivirine Vaginal Ring

N/A Planned/Ongoing Projects

Injectable PrEP

N/A Planned/Ongoing Projects

Policy Frameworks

National Guidelines For Antiretroviral Therapy, 2019

Est. Cumulative
Initiations:

Total PrEP: 108,559

Oral PrEP: 108,559

Dapivirine Vaginal Ring: N/A

Injectable PrEP: N/A

Featured Resources

Document

Namibia Strategic Direction Summary, 2023

Namibia is estimated to be at 92-99-94 as defined by the UNAIDS 95-95-95 treatment cascade, one of the first high burden countries to approach epidemic control Country Operational Plan 2023 (COP23) focuses on closing remaining population and geographic gaps to achieve health equity and end AIDS as a public health threat by 2030 while investing…
External Link

Project Hope Namibia PrEP Communication Toolkit

The CHOICE Collaboration completed a design sprint with Project Hope Namibia to develop new PrEP materials and tools for their DREAMS project. Click here to view and download the final tools that emerged from that process.
View All Resources